Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
64,773,617
-
Share change
-
-227,632
-
Total reported value
-
$4,100,703,173
-
Put/Call ratio
-
96%
-
Price per share
-
$63.13
-
Number of holders
-
242
-
Value change
-
+$3,091,735
-
Number of buys
-
125
-
Number of sells
-
103
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q2 2020
As of 30 Jun 2020,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
242 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,773,617 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, and Capital World Investors.
This page lists
242
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.